Niels Junker

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

Trine Zeeberg Iversen, Niels Junker, Marco Donia et al. · Journal of Translational Medicine · 2012 · 170 citations · Full text

Pharmacy, Immunology, Oncology +16

Dissection of T-cell Antigen Specificity in Human Melanoma

Rikke Andersen, Charlotte Albæk Thrue, Niels Junker et al. · Cancer Research · 2012 · 161 citations

Life Sciences, Immunology, Oncology +17

Blockade of beta-adrenergic receptors reduces cancer growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment

Klaire Yixin Fjæstad, Anne Mette Askehøj Rømer, Victor Goitea et al. · Oncogene · 2022 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Characterization and Comparison of ‘Standard’ and ‘Young’ Tumour‐Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research Institution

Marco Donia, Niels Junker, Mads Hald Andersen et al. · Scandinavian Journal of Immunology · 2011 · 105 citations

Medicine, Immunology, Oncology +17

The Immune System Strikes Back: Cellular Immune Responses against Indoleamine 2,3-dioxygenase

Rikke Bæk Sørensen, Linda Berge-Hansen, Niels Junker et al. · PLoS ONE · 2009 · 69 citations · Full text

Life Sciences, Immunology, Oncology +17